
Intrathecal Methotrexate: A Treatment Option for Patients With Progressive Multiple Sclerosis?
Could intrathecally administered methotrexate be a viable treatment option for your patients with progressive forms of multiple sclerosis?
Could intrathecally administered methotrexate be a viable treatment option for your patients with progressive forms of multiple sclerosis?
Here to discuss the results of a study designed to test the feasibility of this therapeutic approach is neurologist Saud Sadiq. Dr Sadiq is Founder and Director of the
Dr Sadiq and his coauthors published their study in the
Intrathecal Methotrexate for Patients With MS?
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.